Semiconductor Industry Rising from Adversity, Innovative Pharmaceuticals Making Strides Overseas, and Companies on the SSE STAR Market Collaborating to Navigate External Challenges

Cailianpress, April 7 (Reporter Fang Yanbo)

The imposition of 'reciprocal tariffs' by the United States is disrupting the global commercial order, leading to a restructuring of international trade and global supply chains. Against this backdrop, Chinese SSE STAR Market companies, with a focus on independent innovation, are infusing new dynamism into the security and global competitiveness of supply chains.

"China's Chip" Breaks Through Technology Blockades

The integrated circuit industry was once subjected to technology blockades by foreign countries, resulting in a "chip shortage" crisis. However, the SSE STAR Market-listed integrated circuit companies have intensified their R&D investment to improve the resilience and independent controllability of the industrial chain. In chip design, companies like Loongson Technology Corporation Limited and Montage Technology Co., Ltd. have excelled, with the successful tape-out of the Loongson 2K3000 (3B6000M) processor, mastering core and key technologies. In wafer manufacturing, four leading companies, including Semiconductor Manufacturing International Corporation, have been ranked among the top exclusive foundries globally for 2024. Concerning equipment, U.S. tariff policies may raise chip costs, however, companies like Advanced Micro-Fabrication Equipment Inc. China and Piotech Inc. have achieved technological breakthroughs, with Advanced Micro-Fabrication Equipment Inc. China reaching sub-angstrom etching precision and Piotech Inc. consolidating its market position with new products. In materials, SICC Co., Ltd. has launched the 12-inch silicon carbide substrate product, propelling advancements in third-generation semiconductors.

Localization Gains Momentum in High-End Equipment

High-end equipment serves as the backbone of the manufacturing sector, with over 100 SSE STAR Market high-end equipment companies specializing in advanced process equipment that serves key areas of the national economy and people's livelihoods. In industrial mother machines, Kede Numerical Control Co., Ltd. is leveraging its entire industry chain advantages to optimize new quality productive forces, with over 1,300 machines applied in the aerospace sector, achieving an autonomy rate of 85% for core components and a localization rate of 95%. In the power equipment sector, China Southern Power Grid Technology Co., Ltd. is exemplifying innovation by establishing innovation centers and achieving several breakthroughs "from zero to one", thereby ensuring energy security.

Innovative Pharmaceutical Companies Go Global, Strategically Capturing the Global Market

Biomedicine is the core support area for the SSE STAR Market. 20 innovative biopharmaceutical companies are listed according to the fifth set of standards, and 3 unprofitable companies are listed under the red-chip standard. These companies are focusing on cutting-edge technologies and major disease areas. SSE STAR Market has seen frequent innovative achievements. BeiGene, Ltd.'s Zanubrutinib has become a "billion-dollar molecule" to generate nearly 19 billion yuan in global sales in 2024, and Sichuan Biokin Pharmaceutical Co., Ltd.'s dual-antibody ADC new drug authorization has set records by being authorized for global distribution. Dizal (Jiangsu) Pharmaceutical Co., Ltd.'s Sunvozertinib is the world's first targeted drug approved for specific lung cancer. The new drug application was accepted for Priority Review by the U.S. FDA, showcasing the global technological advantages of Chinese innovative pharmaceutical companies.

The above information is provided for reference purposes only and does not constitute investment advice.